Chemical Structure and Pharmacokinetics
The ketolide group shares a direct structural relationship with classical 14-membered macrolides. The fundamental difference of telithromycin lies in the modification of the lactone ring: at the third carbon atom, the cladinose sugar is replaced by a keto group. This exact structural feature gave the entire class of drugs its name.
Furthermore, the telithromycin molecule underwent methylation of the carbon atom at the sixth position. This chemical transformation played a decisive role in the drug's pharmacokinetics—it provided exceptional acid stability. Consequently, the drug is not degraded in the aggressive environment of the stomach.
Absorption in the gastrointestinal tract is stable, and its overall bioavailability is completely independent of food intake, significantly simplifying the dosing regimen for patients. However, clinicians must remain vigilant: telithromycin actively engages in various drug-drug interactions, behaving entirely similarly to erythromycin in this regard.
Mechanism of Action and Overcoming Resistance
The basic mechanism of action of ketolides is similar to that of classical macrolides—they inhibit protein synthesis in the bacterial cell. However, telithromycin demonstrates a significantly higher affinity for the 50S subunit of bacterial ribosomes.
The main secret of the drug's efficacy and its ability to overcome resistance lies in a dual-binding mechanism. Unlike its predecessors, telithromycin not only interacts with the primary target but also firmly binds to an additional site on the 23S rRNA. This enhanced contact prevents bacteria that have already developed defense mechanisms against conventional macrolides from escaping the antibacterial effect. The clinical significance of this is immense: the drug remains highly effective against strains completely resistant to macrolides.
Indications and Safety Profile
In clinical practice, telithromycin has established itself as a potent agent for treating infectious and inflammatory diseases of the respiratory tract and ENT organs. Its main indications include:
- Community-acquired pneumonia;
- Acute exacerbations of chronic obstructive pulmonary disease (COPD);
- Acute bacterial rhinosinusitis;
- Tonsillopharyngitis.
Despite high clinical efficacy, the use of ketolides requires strict monitoring due to adverse effects.
- Common reactions: patients frequently report gastrointestinal disorders (diarrhea, pronounced nausea, vomiting) and intense headaches.
- Rare reactions: in some cases, skin rashes and transient visual disturbances are recorded.
- Particularly dangerous complications: the most severe adverse effect described in medical literature is the development of fulminant hepatic necrosis. Due to the risk of this life-threatening condition, prescribing the drug must be strictly justified.